Skip to content
Subscriber Only

Perrigo Brands to Boost Sales After Record Year, CEO Says

Perrigo Co., the largest U.S. maker of generic over-the-counter drugs, aims to top last year’s record sales by expanding its store brand business and offering new products, Chief Executive Officer Joseph Papa said.

Perrigo will add about $190 million in revenue by selling 45 new drugs in fiscal 2012, about the same number it introduced last year when reporting $2.76 billion in sales, Papa, 56, said in a telephone interview from Allegan, Michigan. Revenue will rise 17 percent to $3.23 billion in 2012, according to the median estimate of 14 analysts surveyed by Bloomberg.